Speciality: Neurology
Description:
A warm welcome to all the medical professionals in this interesting session on Clinical manifestations and diagnosis of Neurocysticercosis.
Neurocysticercosis is a parasitic infection of the central nervous system caused by the larval stage of the pork tapeworm, Taenia sodium. The clinical manifestations vary widely depending on the number, size, and location of cysts in the brain, as well as the host's immune response. Common symptoms include seizures, which are the most frequent clinical presentation, headaches, and focal neurological deficits. Other manifestations can include hydrocephalus, meningitis, cognitive decline, and psychiatric disturbances.
Diagnosis of neurocysticercosis involves a combination of clinical evaluation, neuroimaging, and serological tests. Neuroimaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) are crucial, often revealing characteristic cystic lesions with or without scolex, calcifications, and signs of inflammation. Serological tests, including enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immuno electrotransfer blot (EITB), help detect specific antibodies or antigens and support the diagnosis. Lumbar puncture and cerebrospinal fluid analysis may be used in cases of suspected meningitis or intracranial hypertension. Early and accurate diagnosis is essential for effective management and improving patient outcomes.
Therefore, get an overall knowledge of clinical manifestations and diagnosis of Neurocysticercosis.
See More Webinars @ Hidoc Webinars
1.
Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment
2.
A small rise in cancer was observed following the 1986 Chernobyl accident.
3.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
4.
New research uncovers link between cancer pathway and blood-retina barrier function
5.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
1.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
2.
Survivorship Planning Beyond Active Cancer Care
3.
Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options
4.
Integrated Models in Hematology for Specialists
5.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation